Off-label prescribing during pregnancy

Obstetrics and Gynecology Clinics of North America

Volumn 24, Issue 3, 1997, Pages 471-478

  Rayburn, W F ^a   Farmer, K C ^a  

^a Dept Obstetrics/Gynecology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPICILLIN; BETAMETHASONE; DIGOXIN; GENTAMICIN; INDOMETACIN; MAGNESIUM SULFATE; PENICILLIN DERIVATIVE; PROGESTERONE; PROSTAGLANDIN E2; TERBUTALINE;

CLINICAL PRACTICE; DRUG INDICATION; DRUG LABELING; FOOD AND DRUG ADMINISTRATION; HUMAN; LEGAL ASPECT; MALPRACTICE; MEDICAL DOCUMENTATION; MEDICAL RECORD; PATIENT RIGHT; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; REVIEW;

EID: 0030763093     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8545(05)70317-X     Document Type: Article

References (9)

1. W. Appler G. McMann “Off-label” uses of approved drugs: Limits on physician's prescribing behavior J Clin Psychopharmacol 9 1989 368
2. Drug Topics Redbook 1991 Medical Economics Data Inc Montvale, NJ
3. S.H. Erickson The use of drugs for unlabeled indications JAMA 243 1980 1543
4. Implications of drug labeling and off-label use. Statement of Sarah Jagger before the Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Reform and Oversight, U.S. House of Representatives. GAO Report T-HEHS-96-212, pp 2, 5, 7
5. Physicians' Desk Reference 50th ed 1996 Medical Economics Co Montvale, NJ
6. W.F. Rayburn A physician's prerogative to prescribe drugs for off-label uses during pregnancy Obstet Gynecol 31 1993 1052
7. W. Rayburn E. Prentice Fetal drug therapy: An overview of selected conditions Obstet Gynecol Surv 47 1992 1
8. W. Rayburn G. Turnbull Off-label drug prescribing on a state university obstetric service J Reprod Med 40 1995 186
9. Use of approved drugs for unlabeled indications FDA Drug Bull 12 1982 4